|
151 |
Prevalence, treatments and outcomes of coronary artery disease in Indians: A systematic review |
Rao M, Xavier D, Devi P, Sigamani A, Faruqui A, Gupta R, Kerkar P, Jain RK, Joshi R, Chidambaram N, Rao DS, Thanikachalam S, Iyengar SS, Verghese K, Mohan V, Pais P |
Indian Heart J |
2015 |
|
152 |
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial |
Christopher B. Granger, Renato D. Lopes, Michael Hanna, Jack Ansell, Elaine M. Hylek, John H. Alexander, Laine Thomas, Junyuan Wang, M. Cecilia Bahit, Freek Verheug, Jack Lawrence, *Denis Xavier*, Lars Wallentin. |
American Heart Journal January |
2015 |
|
153 |
Physicians Perception on Complementary and Alternative Medicine (CAM): A Cross Sectional Survey at Tertiary Care Hospital in India |
NS Kunnoor, R Rathore, *D Xavier* |
Medicinal chemistry |
2015 |
|
154 |
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics |
Eva Lonn, Jackie Bosch, Janice Pogue, Alvaro Avezum, *Prem Pais*, *Denis Xavier*, Salim Yusuf, et al. |
Canadian Journal of Cardiology |
2015 |
|
155 |
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease |
Avezum A,Lopes RD, Schulte PJ, Lanas F, Gersh BJ, Hanna M, *Pais P*, Erol C, Diaz R, Bahit MC, Bartunek J, Caterina RD, Goto S, Ruzyllo W, Zhu J, Granger CB & Alexander JH. |
Circulation |
2015 |
|
156 |
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial |
Alexander JH, Lopes RD, Thomas L, Alings M, Atar D, Aylward P, Goto S, Hanna M, Huber K, Husted S, Lewis BS, McMurray JJ, Pais P, Pouleur H, Steg PG, Verheugt FW, Wojdyla DM, Granger CB, Wallentin L |
Eur Heart J |
2014 |
|
157 |
Rationale and design of a randomized controlled trial evaluating community health worker-based interventions for the secondary prevention of acute coronary syndromes in India (SPREAD) |
Kamath DY, Xavier D, Gupta R, Devereaux PJ, Sigamani A, Hussain T, Umesh S, Xavier F, Girish P, George N, Thomas T, Chidambaram N, Joshi R, Pais P, Yusuf S |
Am Heart J |
2014 |
|
158 |
Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE)Trial |
Goto S, Zhu J, Liu L, Oh BH, Wojdyla DM, Aylward P, Bahit MC, Gersh BJ, Hanna M, Horowitz J, Lopes RD, Wallentin L, Xavier D, Alexander JH; ARISTOTLE Investigators |
Am Heart J |
2014 |
|
159 |
Management of NCD in Low- and Middle-Income Countries |
Checkley W, Ghannem H, Irazola V, Kimaiyo S, Levitt NS, Miranda JJ, Niessen L, Prabhakaran D, Rabadán-Diehl C, Ramirez-Zea M, Rubinstein A, Sigamani A, Smith R, Tandon N, Wu Y, Xavier D, Yan LL |
Glob Heart |
2014 |
|
160 |
Management and clinical outcomes in patients treated with apixaban versus warfarin undergoing procedures |
Garcia D, Alexander JH, Wallentin L, Wojdyla DM, Thomas L, Hanna M, Al-Khatib SM, Dorian P, Ansell J, Commerford P, Flaker G, Lanas F, Vinereanu D, Xavier D, Hylek EM, Held C, Verheugt FW, Granger CB, Lopes RD |
Blood |
2014 |
|
161 |
Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes |
Botto F, Alonso-Coello P, Chan MT, Villar JC, Xavier D, et al |
Anesthesiology |
2014 |
|
162 |
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges |
Yusuf S, Attaran A, Bosch J, Joseph P, Lonn E, McCready T, Mente A, Nieuwlaat R, Pais P, Rodgers A, Schwalm JD, Smith R, Teo K, Xavier D |
Eur Heart J |
2014 |
|
163 |
Clonidine in patients undergoing noncardiac surgery |
Devereaux PJ, Sigamani A, Xavier D, Yusuf S, et al |
N Engl J Med |
2014 |
|
164 |
Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial |
Held C, Hylek EM, Alexander JH, Hanna M, Lopes RD, Wojdyla DM, Thomas L, Al-Khalidi H, Alings M, Xavier D, Ansell J, Goto S, Ruzyllo W, Rosenqvist M, Verheugt FW, Zhu J, Granger CB, Wallentin L |
Eur Heart J |
2014 |
|
165 |
Aspirin in patients undergoing noncardiac surgery |
Devereaux PJ, Sigamani A, Xavier D, Yusuf S, et al |
N Engl J Med |
2014 |